Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector May 26, 2026 Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now [...]
ePass Aims to Be Scotland’s Top GovTech Scaleup After Reporting £1M Revenue in First Year May 25, 2026 ePass has set its sights on being Scotland’s most successful GovTech scaleup, following the GovTech startup winning one of the largest CivTech challenges to date, and its tobacco and vapes retailers register being deployed in 6 months, while reporting £1m of revenue in its first twelve months. This press release features multimedia. View the full [...]
Barilla Opens Global Call for Startups Through Good Food Makers 2026 May 25, 2026 The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects.
KBRA Releases Research – European Data Centre Event—KBRA Event Recap May 22, 2026 KBRA releases a recap of its European Data Centre Event in London on 20 May, bringing together sector experts, investors, issuers, operators, bankers, and other market participants for an afternoon of discussions on the key themes shaping the European data centre landscape. The programme focused on how artificial intelligence (AI)-driven demand, power availability, development constraints, [...]
CoStar Data Shows Office Yield Gap Narrowing Between London and the Big Six May 22, 2026 Improving investor sentiment narrows the office yield gap between London and major regional markets, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522576099/en/ Based on a three-quarter trailing average, London’s transaction-based office [...]
Everest Establishes Joseph V. Taranto Scholarship to Advance Commitment to Developing Future Leaders May 21, 2026 Everest Group, Ltd. (NYSE: RE) (“Everest”), a global underwriting leader, today announced the inaugural recipient of the Joseph V. Taranto Scholarship, an annual renewable award and part of the company’s broader commitment to expanding opportunity and developing the next generation of leaders. Established by Everest and its Board of Directors in honor of former Chairman [...]
Expensify and VAT IT Launch Integration Partnership to Simplify Global VAT Reclaim May 21, 2026 Partnership connects Expensify customers with VAT IT’s global VAT reclaim and e-invoicing solutions
Acuity Analytics Launches Domain-Led Agentic AI Platform to Help Financial Institutions Move from Experimentation to Enterprise Value May 21, 2026 Combining agentic AI with deep human expertise to deliver governed, decision ready outcomes.
KKR Invests in Fresha, the Leading AI-Powered Platform for Beauty and Wellness, at $1bn Valuation May 21, 2026 Fresha, the leading AI-powered marketplace and business management platform for the beauty and wellness industry, today announced an $80 million primary growth investment from funds managed by KKR, a leading global investment firm. The transaction values Fresha at over $1 billion, marking a defining milestone in its mission to transform how self-care businesses operate globally. [...]
Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences May 21, 2026 – Real-World Evidence of Positive Impact of LYBALVI® (olanzapine and samidorphan) on Treatment Patterns and Rates of Relapse Among Patients with Schizophrenia or Bipolar I Disorder, Including Young Adults – – APA Plenary Presentation Highlights Recent Clinical Data, Including Results for Negative Symptoms and Outcomes From Four Years of Treatment, and Real-World Evidence From Use of LYBALVI (olanzapine and samidorphan) in Clinical Practice –